Condition: Osteomyelitis · Diabetic Foot Osteomyelitis · Sponsor: Adaptive Phage Therapeutics, Inc.
This is a phase 2b randomized trial designed to evaluate bacteriophage therapy in subjects with diabetic foot osteomyelitis.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Southern Arizona VA Health Care System | Tuscon, Arizona, United States | — |
| NorthBay Healthcare | Fairfield, California, United States | — |
| Harbor Hospital / UCLA | Torrance, California, United States | — |
| Rocky Mountain VA | Aurora, Colorado, United States | — |
| Holy Cross Health | Fort Lauderdale, Florida, United States | — |
| Infectious Disease Consultants od the Treasure Coast | Sebastian, Florida, United States | — |
| Podiatry 1st / Gateway Clinical Trials | O'Fallon, Illinois, United States | — |
| Foot & Ankle Center of Illinois | Springfield, Illinois, United States | — |
| Henry Ford Health | Detroit, Michigan, United States | — |
| Holy Name Medical Center | Teaneck, New Jersey, United States | — |
| CurAlta Foot and Ankle | Westwood, New Jersey, United States | — |
| Futuro Clinical Trials, LLC | McAllen, Texas, United States | — |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05177107